Ventricular tachycardia in the era of ventricular assist devices.
نویسندگان
چکیده
Sustained ventricular tachycardia (VT) in patients with advanced cardiomyopathy is a potentially life-threatening arrhythmia. Newer treatment strategies have evolved that combine the use of catheter ablation to target the substrate for VT and ventricular assist devices (VADs) to hemodynamically support the failing ventricle. This editorial is targeted to the practicing clinician caring for these difficult patients. The current article reviews the use of percutaneous VADs to support catheter ablation of VT, the use of durable VADs to support the failing heart in patients with recurrent VT, ventricular arrhythmias in patients with durable VADs, and the use of catheter ablation to treat VT in patients with durable VADs.
منابع مشابه
Application of centrifugal pump in right ventricular failure due to pulmonary artery hypertension. (A case report)
Background: It has not been yet developed a ost suitable method to treat right ventricular failure due to pulmonar artery hypertention resulted from ventricular arrhythia. Though some case reports about patients ready to heart transplant using left assist device or biventral assist device as bridge have been published in Journals, but nocase concerning application of centrifugal pump for treatm...
متن کاملDesign an Equivalent Left Ventricular Assist Device for Medical Equipment Labs
LVAD is a mechanical pump supporting a weak heart function and blood flow. Sometimes, the heart may not recover fast enough to take over the pumping action immediately after surgery, in such patients a temporary support device has been employed to maintain the pumping action until the patient’s own heart recovers. This device can be considered as a temporary alternative before the process of ar...
متن کاملSuccessful catheter ablation of hemodynamically significant ventricular tachycardia in a patient with biventricular assist device support
Introduction Ventricular assist devices (VADs) are playing a large role in the management of end-stage heart failure. Approximately 35% of patients with a VAD have ventricular arrhythmias within the first month of implantation. Electrophysiologic ablations in the setting of a VAD are limited to left VADs (LVADs). To our knowledge, we describe the first report of ablation of a hemodynamically si...
متن کاملEllagic acid improved arrhythmias induced by CaCL2 in the rat stress model
Objective: In ventricular arrhythmias, due to their free radical scavenging action, antioxidant agents are usually used in the treatment of cardiovascular disease. Since stress is considered as risk factor for increased mortality by causing malignant arrhythmias, the study was designed to evaluate the cardioprotective effects of ellagic acid (EA) on CaCl2-induced arrhythmias in rat stress model...
متن کاملEvaluation of Intravenous Lidocaine to End the Continuous Monomorphic Ventricular Tachycardia in Patients with Coronary Artery Disease (CMD) with or without Healed Myocardial Infarction
ارزشیابی آینده نگر در مورد مصرف لیدوکائین داخل وریدی در درمان تاکیکاردی بطنی مونو مورفیک مداوم در صورت فقدان انفارکتوس حاد میوکارد امری مورد نیاز می باشد. لیدوکائین بعنوان درمان رده اول در بیماران مبتلا به تاکیکاردی بطنی (VT) رواج پیدا کرده است، اما مطالعاتی که کارائی آنرا در آزمایشگاه الکتروفیزیولوژی مورد ارزشیابی قرار می دهد، بیانگر آنست که این دارو اثرات ضعیفی را در پایان دادن به تاکیکاردی ب...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of cardiovascular electrophysiology
دوره 22 3 شماره
صفحات -
تاریخ انتشار 2011